SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-080547
Filing Date
2020-07-02
Accepted
2020-07-02 16:11:11
Documents
1
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3898
  Complete submission text file 0001104659-20-080547.txt   5292
Mailing Address C/O BLUEPRINTS MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
McCain Tracey L (Reporting) CIK: 0001683600 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 201009400

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations